603538 logo

Ningbo Menovo Pharmaceutical Co., Ltd. Stock Price

SHSE:603538 Community·CN¥4.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

603538 Share Price Performance

CN¥22.31
8.53 (61.90%)
CN¥22.31
8.53 (61.90%)
Price CN¥22.31

603538 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Proven track record with adequate balance sheet.

1 Risk
1 Reward

Ningbo Menovo Pharmaceutical Co., Ltd. Key Details

CN¥1.5b

Revenue

CN¥1.1b

Cost of Revenue

CN¥487.3m

Gross Profit

CN¥387.9m

Other Expenses

CN¥99.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 25, 2026
0.45
31.63%
6.46%
53.0%
View Full Analysis

About 603538

Founded
2004
Employees
2404
CEO
Cheng Zhi Yao
WebsiteView website
www.menovopharm.com

Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. The company’s products portfolio includes valsartan, losartan, clopidogrel, perindopril, rosuvastatin calcium, atorvastatin calcium, purin bahrain, and other products. It offers APIs, intermediates, and preparations for the treatment of cardiovascular, central nervous system, gastrointestinal tract, and other therapeutic areas. The company was founded in 2004 and is headquartered in Ningbo, China.

Recent 603538 News & Updates

Recent updates

No updates